Takeda has applied jointly with Netherland’s Norgine Co. which owns all rights on this compound.
Takeda Pharmaceuticals press release, Oct. 30, 2012
Takeda Pharmaceuticals applies in Japan for manufacturing and sales of Cetilistat, a gastric lipase inhibitor to be sold as an antiobesic drug